INTRODUCTION: We report our first clinical experience with a CE-marked flexible monorail balloon-expandable stent for treatment of high-grade intracranial stenoses. METHODS: Between April 2006 and November 2007 21 patients with symptomatic intracranial stenoses (>70%) were treated with the PHAROS stent. In seven patients, the procedure was performed during acute stroke intervention. Procedural success, clinical complication rates and mid-term follow-up data were prospectively recorded. RESULTS: During a median follow-up period of 7.3 months one additional patient died of an unknown cause 3 months after the intervention. A patient with a significant residual stenosis presented with a new stroke after further progression of the residual stenosis. None of the successfully treated patients experienced ipsilateral stroke. CONCLUSION: Recanalization of intracranial stenoses with the balloon-expandable Pharos stent is technically feasible. The periprocedural complication rate and mid-term follow-up results were in the range of previously reported case series. This pilot study was limited by the small sample size and severe morbidity of the included patients. Final evaluation of the efficacy of Pharos stent treatment demands further investigation.
INTRODUCTION: We report our first clinical experience with a CE-marked flexible monorail balloon-expandable stent for treatment of high-grade intracranial stenoses. METHODS: Between April 2006 and November 2007 21 patients with symptomatic intracranial stenoses (>70%) were treated with the PHAROS stent. In seven patients, the procedure was performed during acute stroke intervention. Procedural success, clinical complication rates and mid-term follow-up data were prospectively recorded. RESULTS: During a median follow-up period of 7.3 months one additional patient died of an unknown cause 3 months after the intervention. A patient with a significant residual stenosis presented with a new stroke after further progression of the residual stenosis. None of the successfully treated patients experienced ipsilateral stroke. CONCLUSION: Recanalization of intracranial stenoses with the balloon-expandable Pharos stent is technically feasible. The periprocedural complication rate and mid-term follow-up results were in the range of previously reported case series. This pilot study was limited by the small sample size and severe morbidity of the included patients. Final evaluation of the efficacy of Pharos stent treatment demands further investigation.
Authors: Elad I Levy; Aquilla S Turk; Felipe C Albuquerque; David B Niemann; Beverly Aagaard-Kienitz; Lee Pride; Phil Purdy; Babu Welch; Henry Woo; Peter A Rasmussen; L Nelson Hopkins; Thomas J Masaryk; Cameron G McDougall; David J Fiorella Journal: Neurosurgery Date: 2007-09 Impact factor: 4.654
Authors: Philip M Meyers; H Christian Schumacher; Kurenai Tanji; Randall T Higashida; Louis R Caplan Journal: Annu Rev Med Date: 2007 Impact factor: 13.739
Authors: David Fiorella; Michael M Chow; Michael Anderson; Henry Woo; Peter A Rasmussen; Thomas J Masaryk Journal: Neurosurgery Date: 2007-08 Impact factor: 4.654
Authors: Wiebke Kurre; Friedhelm Brassel; Roland Brüning; Jan Buhk; Bernd Eckert; Susanna Horner; Michael Knauth; Thomas Liebig; Jana Maskova; Dirk Mucha; Vojtech Sychra; Matthias Sitzer; Michael Sonnberger; Marc Tietke; Johannes Trenkler; Bernd Turowski; Joachim Berkefeld Journal: Neuroradiology Date: 2011-01-11 Impact factor: 2.804
Authors: Jeremy D Fields; Kenneth C Liu; Stanley L Barnwell; Wayne M Clark; Helmi L Lutsep Journal: Curr Cardiol Rep Date: 2010-01 Impact factor: 2.931
Authors: F Al-Ali; T Cree; L Duan; S Hall; A Jefferson; S Louis; K Major; S Smoker; S Walker Journal: AJNR Am J Neuroradiol Date: 2011-07-21 Impact factor: 3.825
Authors: Zsolt Vajda; Elina Miloslavski; Thomas Güthe; Elisabeth Schmid; Christoph Schul; Guido Albes; Hans Henkes Journal: Neuroradiology Date: 2009-11-17 Impact factor: 2.804